Want to join the conversation?
$MRK said it achieved two regulatory milestones for its investigational vaccine for Ebola Zaire. The U.S. Food and Drug Administration (FDA) granted the vaccine candidate Breakthrough Therapy Designation, and the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) status, the company said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.